13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001920938
申報總市值
US$27.0億
US$27.0億
73 檔
27.6%
Braidwell LP 在 Q4 2024 季度的美股部位總計估值為 US$27.0億，分散於 73 個持倉標的之中，反映其市場參與廣度與投資規模。
觀察 Q4 2024 的資金脈絡，Braidwell LP 在獲利結算 22 檔個股的同時，將資本重新部署至 14 檔新選標的，展現主動管理機構的輪動節奏。
從部位權重觀察，前 5 大標的（包含 GH 0 11-15-27, BBIO 2.5 03-15-27, NVCR 0 11-01-25）累計市值佔比達 27.6%，是驅動 Braidwell LP 該季度整體投資組合績效表現的核心支柱。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 0 11-15-27債券 | Guardant Health Inc | 債券 | 6.70% | — | — | |
| 2 | BBIO 2.5 03-15-27債券 | Bridgebio Pharma Inc | 債券 | 4.39% | — | — | |
| 3 | NVCR 0 11-01-25債券 | Novocure LTD | 債券 | 3.99% | — | — | |
| 4 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 3.65% | -0.77% | -1.73% | |
| 5 | RGEN 1 12-15-28債券 | Repligen CORP | 債券 | 3.40% | -2.68% | — | |
| 6 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.39% | -0.07% | +7.64% | |
| 7 | GMED 0.375 03-15-25債券 | Nuvasive Inc | 債券 | 3.36% | — | — | |
| 8 | NEO 0.25 01-15-28債券 | Neogenomics Inc | 債券 | 2.91% | -2.44% | — | |
| 9 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 2.87% | — | +93.18% | |
| 10 | CGON | Cg Oncology Inc | 股票-其他 | 2.79% | -2.22% | EXIT | |
| 11 | GH | Guardant Health Inc | 股票-醫療保健 | 2.58% | -0.72% | -14.79% | |
| 12 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | 債券 | 2.53% | — | — | |
| 13 | ALGN | Align Technology Inc | 股票-醫療保健 | 2.32% | — | +20.37% | |
| 14 | DXCM 0.375 05-15-28債券 | Dexcom Inc | 債券 | 2.21% | — | -10.79% | |
| 15 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.07% | -1.34% | EXIT | |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 2.02% | -0.01% | +19.28% | |
| 17 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 1.99% | — | -32.84% | |
| 18 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 1.89% | +0.48% | -9.86% | |
| 19 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.85% | +0.53% | +19.09% | |
| 20 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 1.83% | — | — | |
| 21 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.78% | +1.32% | +17.74% | |
| 22 | VKTX | Viking Therapeutics Inc | 股票-醫療保健 | 1.77% | — | +27.89% | |
| 23 | TMDX | Transmedics Group Inc | 股票-醫療保健 | 1.70% | +0.41% | — | |
| 24 | ATEC 0.75 08-01-26債券 | Alphatec Holdings Inc | 債券 | 1.63% | — | — | |
| 25 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 1.61% | -0.05% | +22.81% | |
| 26 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 1.47% | -1.46% | -16.50% | |
| 27 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.38% | +0.14% | — | |
| 28 | BBIO 2.25 02-01-29債券 | Bridgebio Pharma Inc | 債券 | 1.36% | — | — | |
| 29 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 1.35% | +1.04% | — | |
| 30 | SRPT | Sarepta Therapeutics Inc | 股票-醫療保健 | 1.32% | — | -1.48% | |
| 31 | PEN | Penumbra Inc | 股票-醫療保健 | 1.29% | -1.15% | EXIT | |
| 32 | GKOS | Glaukos CORP | 股票-醫療保健 | 1.28% | +0.32% | -7.30% | |
| 33 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 1.28% | — | +21.15% | |
| 34 | RGEN | Repligen CORP | 股票-醫療保健 | 1.21% | +0.70% | -28.47% | |
| 35 | FNAUSD | Paragon 28 Inc | 股票-其他 | 1.17% | — | -7.26% | |
| 36 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 1.17% | -0.16% | -17.52% | |
| 37 | ATEC | Alphatec Holdings Inc | 股票-其他 | 1.16% | +1.30% | +5.33% | |
| 38 | BNTX | Biontech Se-adr | 股票-其他 | 1.05% | — | +25.07% | |
| 39 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 1.03% | — | +20.70% | |
| 40 | KRYS | Krystal Biotech Inc | 股票-醫療保健 | 0.93% | +0.20% | +18.86% | |
| 41 | HROW | Harrow Inc | 股票-其他 | 0.90% | -0.18% | EXIT | |
| 42 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.89% | — | +167.86% | |
| 43 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.80% | +0.98% | NEW | |
| 44 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.78% | -0.38% | +144.40% | |
| 45 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.76% | +0.20% | — | |
| 46 | ✓ | Immatics NV | 股票-其他 | 0.74% | — | +112.68% | |
| 47 | GERN | Geron CORP | 股票-其他 | 0.74% | — | — | |
| 48 | IRWD | Ironwood Pharmaceuticals Inc | 股票-其他 | 0.71% | — | +22.58% | |
| 49 | BRKR | Bruker CORP | 股票-醫療保健 | 0.61% | — | — | |
| 50 | EXK | Exact Sciences CORP | 股票-原物料 | 0.59% | — | +23.35% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | RGEN 1 12-15-28債券 | Repligen CORP | +3.4% | NEW | 新建倉 |
| 2 | TMDX | Transmedics Group Inc | +1.7% | NEW | 新建倉 |
| 3 | TMO | Thermo Fisher Scientific Inc | +1.4% | NEW | 新建倉 |
| 4 | GERN | Geron CORP | +0.7% | NEW | 新建倉 |
| 5 | LEGN | Legend Biotech Corp-adr | +0.7% | +93.18% | 加碼 |
| 6 | NBIX | Neurocrine Biosciences Inc | +0.7% | -1.73% | 減碼 |
| 7 | BRKR | Bruker CORP | +0.6% | NEW | 新建倉 |
| 8 | GH 0 11-15-27債券 | Guardant Health Inc | +0.6% | — | 不變 |
| 9 | NUVL | Nuvalent Inc-a | +0.6% | NEW | 新建倉 |
| 10 | ATEC | Alphatec Holdings Inc | +0.5% | +5.33% | 加碼 |
| 11 | DYN | Dyne Therapeutics Inc | +0.5% | NEW | 新建倉 |
| 12 | ORKA | Oruka Therapeutics Inc | +0.4% | +122.54% | 加碼 |
| 13 | CADL | Candel Therapeutics Inc | +0.4% | NEW | 新建倉 |
| 14 | GH | Guardant Health Inc | +0.4% | -14.79% | 減碼 |
| 15 | DNTH | Dianthus Therapeutics Inc | +0.4% | +144.40% | 加碼 |
| 16 | FNAUSD | Paragon 28 Inc | +0.4% | -7.26% | 減碼 |
| 17 | EWTX | Edgewise Therapeutics Inc | +0.4% | +19.09% | 加碼 |
| 18 | XENE | Xenon Pharmaceuticals Inc | +0.4% | +7.64% | 加碼 |
| 19 | RCUS | Arcus Biosciences Inc | +0.4% | NEW | 新建倉 |
| 20 | HROW | Harrow Inc | +0.3% | +106.31% | 加碼 |
| 21 | BBIO 2.5 03-15-27債券 | Bridgebio Pharma Inc | +0.3% | — | 不變 |
| 22 | IRTC | Irhythm Holdings Inc | +0.2% | -9.86% | 減碼 |
| 23 | BNTX | Biontech Se-adr | +0.2% | +25.07% | 加碼 |
| 24 | ✓ | Immatics NV | +0.2% | +112.68% | 加碼 |
| 25 | NVCR 0 11-01-25債券 | Novocure LTD | +0.2% | — | 不變 |
| 26 | JSPR | Jasper Therapeutics Inc | +0.2% | +47.87% | 加碼 |
| 27 | IRWD | Ironwood Pharmaceuticals Inc | +0.2% | +22.58% | 加碼 |
| 28 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | +0.2% | — | 不變 |
| 29 | GMED 0.375 03-15-25債券 | Nuvasive Inc | +0.2% | — | 不變 |
| 30 | INSP | Inspire Medical Systems Inc | +0.2% | +22.81% | 加碼 |
| 31 | CBLL | Ceribell Inc | +0.2% | NEW | 新建倉 |
| 32 | NEO 0.25 01-15-28債券 | Neogenomics Inc | +0.2% | — | 不變 |
| 33 | XNCR | Xencor Inc | +0.2% | +31.96% | 加碼 |
| 34 | ATEC 0.75 08-01-26債券 | Alphatec Holdings Inc | +0.1% | — | 不變 |
| 35 | GKOS | Glaukos CORP | +0.1% | -7.30% | 減碼 |
| 36 | ✓ | +0.1% | NEW | 新建倉 | |
| 37 | BBIO 2.25 02-01-29債券 | Bridgebio Pharma Inc | +0.1% | — | 不變 |
| 38 | SKYE | Skye Bioscience Inc | +0.1% | NEW | 新建倉 |
| 39 | ALGN | Align Technology Inc | +0.1% | +20.37% | 加碼 |
| 40 | KRYS | Krystal Biotech Inc | +0.1% | +18.86% | 加碼 |
| 41 | EXK | Exact Sciences CORP | 0% | +23.35% | 加碼 |
| 42 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +21.15% | 加碼 |
| 43 | PTGX | Protagonist Therapeutics Inc | 0% | NEW | 新建倉 |
| 44 | VRDN | Viridian Therapeutics Inc | 0% | NEW | 新建倉 |
| 45 | SRPT | Sarepta Therapeutics Inc | 0% | -1.48% | 減碼 |
| 46 | ✓ | Elevation Oncology Inc | 0% | EXIT | 清倉 |
| 47 | ARGX | Argenx Se - Adr | 0% | -16.50% | 減碼 |
| 48 | KNSA | Kiniksa Pharmaceuticals International, plc | 0% | +19.28% | 加碼 |
| 49 | CELC | Celcuity Inc | 0% | — | 不變 |
| 50 | ✓ | Dbv Technologies S A | 0% | EXIT | 清倉 |
根據 SEC 官方 Form 13F 申報備案，Braidwell LP 在 Q4 2024 季度的美股持倉總市值約為 US$27.0億，共申報了 73 個公開持股部位。
在 Q4 2024 季度，Braidwell LP 按市值排列的前三大核心持股分別為：GH 0 11-15-27 (6.7%)、BBIO 2.5 03-15-27 (4.4%)、NVCR 0 11-01-25 (4.0%)。其中最大持股部位 GH 0 11-15-27 佔據整體投資組合約 6.7% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
RGEN 1 12-15-28
市值: US$1.1億
本季最大獲利了結 / 清倉標的
PODD 0.375 09-01-26
前期市值: US$7638.5萬
在 Q4 2024 季度中，Braidwell LP 共進行了 76 項持倉異動，包含新建倉 14 個部位、加碼 23 個部位、減碼 17 個部位以及清倉 22 個部位。 其中最大新建倉標的為 RGEN 1 12-15-28。 本季清倉部位包含 PODD 0.375 09-01-26。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。